Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Marathon Petroleum Corp (MPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Marathon Petroleum Corp — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while Marathon Petroleum Corp trades at $489.67 (market cap $133.95B). The key difference: Marathon Petroleum Corp is far larger — about 15.1× Kymera Therapeutics Inc. Common Stock's market cap, and Marathon Petroleum Corp pays a 0.84% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Marathon Petroleum Corp for 53 Days on average.
| KYMR | MPC | |
|---|---|---|
Market Cap | $8.87B | $133.95B |
Volume | 779,107 | 1,644,329 |
Sector | Health | Energy |
52-Week High | $127.31 | $484.92 |
52-Week Low | $55.80 | $162.63 |
Typical Hold Time | 0 Days | 53 Days |
Enterprise Value | $8.26B | $160.47B |
Dividend Yield | — | 0.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Marathon Petroleum (MPC) trades at $476.98, up 3.96% with strong bullish momentum. The stock demonstrates robust fundamentals with consistent earnings beats, a 47.9% ROE, and attractive valuation metrics including a 16.54 P/E ratio. Technical indicators show bullish moving averages while RSI suggests overbought conditions near resistance at $479. Recent news highlights refining margin strength amid tight global capacity.
MPC presents a compelling investment case with strong profitability and analyst support (75.8% buy ratings), though current price exceeds consensus target. Key risks include potential diesel export restrictions and cyclical refining margins. The company's cash flow recovery and dividend stability provide shareholder value support amid energy sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →
